News from volitionrx limited A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-PINK:VNRX,OTC-QB:VNRX)

Dec 02, 2013, 06:30 ET

VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...

Nov 29, 2013, 08:30 ET

VolitionRx to Present at the 6th Annual LD Micro Conference

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...

Nov 14, 2013, 06:30 ET

VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark

VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...

Nov 07, 2013, 06:30 ET

First VolitionRx Study Data Presented at CNAPS, Baltimore

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...

Sep 26, 2013, 06:30 ET

VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...

Sep 03, 2013, 06:30 ET

VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is...

Jul 22, 2013, 06:30 ET

VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits

VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive...

May 01, 2013, 06:30 ET

Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic

VolitionRx Limited (OTC: VNRX), a life sciences company that is developing blood-based diagnostic tests for different types of cancer, has retained...

Apr 04, 2013, 06:30 ET

VolitionRx Files Two Patent Applications

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has filed two...

Mar 26, 2013, 07:00 ET

VolitionRx Hires Head of US Operations, Jason Terrell MD

VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has hired Jason...

Jan 09, 2013, 06:30 ET

VolitionRx Announces Collaboration with Wales Cancer Bank

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a...

Dec 17, 2012, 06:30 ET

Volition Launches NuQ® Epigenetic Immunoassays for Research Use

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces the launch of NuQ®,...

Nov 05, 2012, 06:30 ET

VolitionRx's Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced preliminary...

Aug 21, 2012, 06:30 ET

VolitionRX to Begin Prospective Clinical Trial in Colon Cancer

 VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition...

Jul 16, 2012, 06:30 ET

VolitionRX Issues CEO Letter to Shareholders

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, issues the following letter to...

Jul 09, 2012, 06:30 ET

VolitionRX Signs Collaboration Agreement With Stefan Holdenrieder of Rheinische Friedrich-Wilhelms-Universitat Bonn Germany

VolitionRX Limited (OTC:VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce that it has...

May 14, 2012, 08:00 ET

VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce the closure...

Mar 27, 2012, 19:01 ET
How VolitionRX's Nucleosomics Technology Works.  (PRNewsFoto/VolitionRX Limited)

Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer

The ability to diagnose disease early has long been a goal in the medical arena. VolitionRX (VNRX.OB), a life sciences company, is pioneering...

Feb 17, 2012, 05:00 ET

Volition Signs Collaboration Agreement With Abcodia

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, announces a collaboration agreement...

Dec 22, 2011, 07:00 ET

VolitionRX Limited Intellectual Property Update: New Patent Filed

VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce that it has filed...